Literature DB >> 16175443

Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia.

Mark A Westwood1, David N Firmin, Matta Gildo, Galanello Renzo, Gotsis Stathis, Karagiorga Markissia, Berdoukas Vasili, Dudley J Pennell.   

Abstract

In transfusion-dependent thalassemia major, iron-induced cardiomyopathy is the predominant cause of morbidity and mortality. Assessment of myocardial iron loading using MRI gradient echo T2* measurements have been described, but has only been performed at one centre in London. We assessed the transferability of this method by comparing the results from three different MR scanners in three different countries. Ten patients with thalassemia major underwent myocardial T2* assessment using a Siemens Sonata Scanner in London. Patients were also scanned with either a similar T2* sequence on a GE Systems CVI scanner in Athens, or a GE Systems signa echospeed scanner in Cagliari. Two scans were performed at the respective site in all patients to assess interstudy reproducibility at each site. The mean difference and coefficient of variability for the heart between scanners was 0.08 ms and 9.7% between London and Athens; and 0.30 ms and 1.6% between London and Cagliari. The interstudy mean difference and coefficient of variability for the heart in Athens was 0.6 ms and 3.5%, and 0.2 ms and 2.4% in Cagliari. In conclusion, the myocardial iron estimations were consistent between the three centres with scanners of differing manufacture, suggesting that this technique may have widespread application in the assessment of patients with iron overload conditions such as thalassaemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175443     DOI: 10.1007/s10554-005-0651-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  7 in total

1.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors:  L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

2.  Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia.

Authors:  Mark A Westwood; Lisa J Anderson; David N Firmin; Peter D Gatehouse; Christine H Lorenz; Beatrix Wonke; Dudley J Pennell
Journal:  J Magn Reson Imaging       Date:  2003-11       Impact factor: 4.813

3.  Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia.

Authors:  Lisa J Anderson; Beatrix Wonke; Emma Prescott; Sally Holden; J Malcolm Walker; Dudley J Pennell
Journal:  Lancet       Date:  2002-08-17       Impact factor: 79.321

Review 4.  The thalassaemias.

Authors:  D J Weatherall
Journal:  BMJ       Date:  1997-06-07

5.  Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register.

Authors:  B Modell; M Khan; M Darlison
Journal:  Lancet       Date:  2000-06-10       Impact factor: 79.321

6.  A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload.

Authors:  Mark Westwood; Lisa J Anderson; David N Firmin; Peter D Gatehouse; Clare C Charrier; Beatrix Wonke; Dudley J Pennell
Journal:  J Magn Reson Imaging       Date:  2003-07       Impact factor: 4.813

7.  Clinical consequences of acquired transfusional iron overload in adults.

Authors:  A I Schafer; R G Cheron; R Dluhy; B Cooper; R E Gleason; J S Soeldner; H F Bunn
Journal:  N Engl J Med       Date:  1981-02-05       Impact factor: 91.245

  7 in total
  36 in total

1.  Role of CMR feature-tracking derived left ventricular strain in predicting myocardial iron overload and assessing myocardial contractile dysfunction in patients with thalassemia major.

Authors:  Vineeta Ojha; Kartik P Ganga; Tulika Seth; Ambuj Roy; Nitish Naik; Priya Jagia; Gurpreet S Gulati; Sanjeev Kumar; Sanjiv Sharma
Journal:  Eur Radiol       Date:  2021-03-15       Impact factor: 5.315

Review 2.  Liver iron content determination by magnetic resonance imaging.

Authors:  Konstantinos Tziomalos; Vassilios Perifanis
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

3.  Cardiovascular magnetic resonance and thalassaemia.

Authors:  J P Carpenter; D J Pennell
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-02       Impact factor: 2.357

4.  Cardiac R2* values are independent of the image analysis approach employed.

Authors:  Antonella Meloni; Hugh Young Rienhoff; Amber Jones; Alessia Pepe; Massimo Lombardi; John C Wood
Journal:  Magn Reson Med       Date:  2013-10-01       Impact factor: 4.668

Review 5.  Quantification of liver iron with MRI: state of the art and remaining challenges.

Authors:  Diego Hernando; Yakir S Levin; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

6.  Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification.

Authors:  Taigang He; Peter D Gatehouse; Gillian C Smith; Raad H Mohiaddin; Dudley J Pennell; David N Firmin
Journal:  Magn Reson Med       Date:  2008-11       Impact factor: 4.668

7.  Intensive chelation therapy in beta-thalassemia and possible adverse cardiac effects of desferrioxamine.

Authors:  Athanassios Aessopos; Maria Kati; Dimitrios Farmakis; Ekaterini Polonifi; Spyros Deftereos; Maria Tsironi
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

8.  Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias.

Authors:  Sarah Deborah Chirnomas; Marnix Geukes-Foppen; Kristen Barry; Jennifer Braunstein; Leslie A Kalish; Ellis J Neufeld; Andrew J Powell
Journal:  Am J Hematol       Date:  2008-10       Impact factor: 10.047

9.  The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study.

Authors:  Vasilios Berdoukas; Giorgos Chouliaras; Panagiotis Moraitis; Kirykos Zannikos; Eleni Berdoussi; Vassilios Ladis
Journal:  J Cardiovasc Magn Reson       Date:  2009-06-28       Impact factor: 5.364

10.  Prevention of cardiomyopathy in transfusion-dependent homozygous thalassaemia today and the role of cardiac magnetic resonance imaging.

Authors:  Athanassios Aessopos; Vasilios Berdoukas; Maria Tsironi
Journal:  Adv Hematol       Date:  2009-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.